Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | NEK2 | P51955 | 1/20 | 0.38 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30502409 | 1.00 | CYP2D6 (0.43) | CYP2D6MCL1EP300KAT2BKAT8 | |
| Hydrochloric Acid SCHEMBL28101819 | 0.98 | EP300 (0.43) | CYP2D6MCL1EP300KAT2BKAT8 | |
| Acetonitrile SCHEMBL28255271 | 0.91 | EP300 (0.38) | CYP2D6MCL1EP300KAT2BKAT8 | |
| SCHEMBL2964374 | 0.84 | CHEK1 (0.39) | MCL1EP300KAT2BKAT8SIGMAR1 | |
| SCHEMBL6045799 | 0.84 | CYP2D6 (0.42) | CYP2D6SIGMAR1MAPTMEN1GAA | |
| SCHEMBL726452 | 0.83 | CA2 (0.47) | MCL1EP300KAT2BKAT8CNR2 | |
| SCHEMBL29773602 | 0.83 | CA2 (0.47) | MCL1EP300KAT2BKAT8CNR2 | |
| SCHEMBL1660887 | 0.83 | PAX8 (0.41) | MCL1EP300KAT2BKAT8SIGMAR1 | |
| SCHEMBL9283373 | 0.83 | CYP2D6 (0.43) | CYP2D6TDP1MAPTGAAKMT2A | |
| SCHEMBL5608087 | 0.83 | SIGMAR1 (0.40) | MCL1EP300KAT2BKAT8SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108530639-A | Efficient water-coal-slurry thinner | 青岛艾尔乐新材料有限公司 | 2018-09-14 | — | — | CN | claimed |
| CN-108315068-A | Method for water-coal-slurry viscosity reduction | 青岛艾尔乐新材料有限公司 | 2018-07-24 | — | — | CN | claimed |
| US-20080064645-A1 | Non-Natural Sphingolipid Analogs and Uses Thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-03-13 | — | — | US | claimed |
| US-12071350-B2 | Modified carbon nanomaterial, nanocluster, substance delivery carrier and pharmaceutical composition | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2024-08-27 | — | — | US | disclosed |
| US-11971419-B2 | Hydroxycholesterol immunoassay | ENZO LIFE SCIENCES, INC. (US) | 2024-04-30 | — | — | US | disclosed |
| WO-2023026315-A1 | DEVELOPMENT OF QUALITY CONTROL TECHNOLOGY FOR PHARMACEUTICAL FORMULATION HAVING RNA ENCAPSULATED IN LIPID MEMBRANE | 国立大学法人東北大学 | 2023-03-02 | — | — | WO | disclosed |
| US-20220169517-A1 | MODIFIED CARBON NANOMATERIAL, NANOCLUSTER, SUBSTANCE DELIVERY CARRIER AND PHARMACEUTICAL COMPOSITION | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2022-06-02 | — | — | US | disclosed |
| EP-3939936-A1 | MODIFIED CARBON NANOMATERIAL, NANOCLUSTER, SUBSTANCE DELIVERY CARRIER AND PHARMACEUTICAL COMPOSITION | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2022-01-19 | — | — | EP | disclosed |
| US-20210302445-A1 | HYDROXYCHOLESTEROL IMMUNOASSAY | ENZO LIFE SCIENCES, INC. (US) | 2021-09-30 | — | — | US | disclosed |
| US-10718777-B2 | Combined histological stain | AGILENT TECHNOLOGIES, INC. (US) | 2020-07-21 | — | — | US | disclosed |
| CN-108315068-B | Method for reducing viscosity of coal water slurry | 青岛艾尔乐新材料有限公司 | 2020-04-21 | — | — | CN | disclosed |
| EP-0606925-A2 | A method for derivatizing a 1-amino-1-deoxyoligosaccharide | Genzyme Corporation (US) | 1994-07-20 | — | — | EP | disclosed |
| US-5324828-A | Fluorescent compound | GENZYME CORPORATION (US) | 1994-06-28 | — | — | US | disclosed |
| US-5283353-A | Enzymeric cleavage from glycoprotein | GENZYME CORPORATION (US) | 1994-02-01 | — | — | US | disclosed |
| EP-0575927-A2 | Process for liming skins and hides | RÖHM GMBH (DE) | 1993-12-29 | — | — | EP | disclosed |
| US-5262545-A | Used to study transcriptional control sequence in the field of endocrinology, microbiology, virology, genetics and oncology | MOLECULAR PROBES, INC. (US) | 1993-11-16 | — | — | US | disclosed |
| US-5262545-A | Used to study transcriptional control sequence in the field of endocrinology, microbiology, virology, genetics and oncology | MOLECULAR PROBES, INC. (US) | 1993-11-16 | — | — | US | disclosed |
| US-5215890-A | Chromogenic substrate to peroxidase enzymes | THEODOROPULOS SPYROS (US) | 1993-06-01 | — | — | US | disclosed |
| EP-0110173-B1 | TEST DEVICE AND METHOD FOR IN A COLORED AQUEOUS FLUID BY DIFFUSE REFLECTANCE DETECTING A SOLUBLE ANALYTE MEASUREMENT | Lifescan, Inc. (US) | 1987-03-04 | — | — | EP | disclosed |
| EP-0110173-A1 | Test device and method for in a colored aqueous fluid by diffuse reflectance detecting a soluble analyte measurement | Lifescan, Inc. (US) | 1984-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064645-A1 | Non-Natural Sphingolipid Analogs and Uses Thereof | SGMS1, BST2, SELPLG | CYP2D6 4867/4885MCL1 1168/4885EP300 4137/4885 |
| US-20210302445-A1 | HYDROXYCHOLESTEROL IMMUNOASSAY | CYP46A1, CYP27A1, DHCR7 | CYP2D6 624/4885MCL1 4681/4885EP300 1900/4885 |
| US-11971419-B2 | Hydroxycholesterol immunoassay | CYP46A1, CYP27A1, DHCR7 | CYP2D6 624/4885MCL1 4681/4885EP300 1900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.